Skip to main content
Premium Trial:

Request an Annual Quote

OGT Shutters Nonessential Tridend Unit as It Bets on New Arrays, Markets

BOSTON (GenomeWeb News) — Oxford Gene Technology has closed one of its business units as it concentrates on developing and launching new microarray products and growing its licensing revenue in newer markets like Japan, according to a company official.
 
OGT's CEO Mike Evans said this week that OGT had decided to close down the unit, called Tridend, because it "didn't fit with OGT's core strategy." Evans spoke with GenomeWeb News at IBC Life Sciences' Discovery 2 Diagnostics conference, held here this week.
 
Evans said that OGT will now "look at ways of utilizing the Tridend technology externally" with partners and is considering licensing opportunities for the IP behind Tridend.
 
Evans told GenomeWeb News sister publication BioArray News in May 2005 that Tridend is focused on commercializing the firm's mass spectrometry technology for applications such as genotyping or protein characterization. The unit was one in development as the company sought to expand its business beyond licensing.
 
In recent months, however, OGT has been more focused on launching a series of prokaryotic chromatin immunoprecipitation (ChIP)-on-chip arrays as well as chips for comparative genomic hybridization.
 
The firm also signed four licensing deals in Japan in August, and signed another licensing deal with Invitrogen last week.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.